1-3 of 3
Anderson Clark
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Preclinical Pharmacology of Tepotinib—A Highly Selective MET Inhibitor with Activity in Tumors Harboring MET Alterations

Joachim Albers, Manja Friese-Hamim, Anderson Clark, Oliver Schadt, Gina Walter-Bausch, Christopher Stroh, Andreas Johne, Niki Karachaliou, Andree Blaukat
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (7): 833–843.
https://doi.org/10.1158/1535-7163.MCT-22-0537
Published: 05 July 2023
View article titled, The Preclinical Pharmacology of Tepotinib—A Highly Selective MET Inhibitor with Activity in Tumors Harboring <em>MET</em> Alterations
Open the PDF for The Preclinical Pharmacology of Tepotinib—A Highly Selective MET Inhibitor with Activity in Tumors Harboring <em>MET</em> Alterations in another window
Journal Articles

Abstract A162: Identification of brain penetrant p70S6K/Akt inhibitor MSC2363318A.

Bayard R. Huck, Andreas Machl, Erik Wilker, Hui Tian, Sakeena Syed, Jing Lin, Jianguo Ma, Anderson Clark, Roseann Waterhouse, Remiguisz Kaleta, Alina Micu, Lynne Soughley, Long Li, Karin Groll, Sonja Kroesser, Frank Beier, Ursula Hering, Marc Lecomte, Katrin Wichert, Mauro D'Antonio, Paolo Di Eugenio
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A162.
https://doi.org/10.1158/1535-7163.TARG-13-A162
Published: 01 November 2013
View article titled, Abstract A162: Identification of brain penetrant p70S6K/Akt inhibitor MSC2363318A.
Journal Articles

Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts

Angela Romanelli, Anderson Clark, Franck Assayag, Sophie Chateau-Joubert, Marie-France Poupon, Jean-Luc Servely, Jean-Jacques Fontaine, Xiaohong Liu, Edward Spooner, Samantha Goodstal, Patricia de Cremoux, Ivan Bièche, Didier Decaudin, Elisabetta Marangoni
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (12): 2693–2703.
https://doi.org/10.1158/1535-7163.MCT-12-0441-T
Published: 09 December 2012
View article titled, Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts
Open the PDF for Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts in another window
Includes: Supplementary data